Andrew Elzinga

Senior Manager


  • Boston


Andrew Elzinga provides support in litigation and regulatory investigations, within the context of antitrust and competition and intellectual property, and with a focus on the healthcare and life sciences industries. Dr. Elzinga works with attorneys and academic experts to perform economic analyses in all phases of the litigation process, including the submission of expert reports, deposition, and trial.

Selected industry experience
  • Biologic drugs, health insurance, and pharmaceuticals
Professional Affiliations

Economic Issues in Assessing Potential and Nascent Competition


Fresenius Kabi USA LLC v. Par Sterile Products LLC et al.


Expectations for Healthcare Mergers During the Pandemic


Healthcare Merger Analysis


Cigna’s Acquisition of Express Scripts

  • “Pharmacy Benefit Managers: Economics and Enforcement Interest,” 49th Annual Conference on International Antitrust Law and Policy and Antitrust Economics Workshops, Fordham University School of Law, 14 September 2022